Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 51

1.

YKL-40: a novel prognostic fluid biomarker for preclinical Alzheimer's disease.

Craig-Schapiro R, Perrin RJ, Roe CM, Xiong C, Carter D, Cairns NJ, Mintun MA, Peskind ER, Li G, Galasko DR, Clark CM, Quinn JF, D'Angelo G, Malone JP, Townsend RR, Morris JC, Fagan AM, Holtzman DM.

Biol Psychiatry. 2010 Nov 15;68(10):903-12. doi: 10.1016/j.biopsych.2010.08.025. Erratum in: Biol Psychiatry. 2011 Feb 15;69(4):389.

2.

CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis.

Olsson B, Lautner R, Andreasson U, Öhrfelt A, Portelius E, Bjerke M, Hölttä M, Rosén C, Olsson C, Strobel G, Wu E, Dakin K, Petzold M, Blennow K, Zetterberg H.

Lancet Neurol. 2016 Jun;15(7):673-684. doi: 10.1016/S1474-4422(16)00070-3. Epub 2016 Apr 8. Review.

PMID:
27068280
3.

Biomarker discovery for Alzheimer's disease, frontotemporal lobar degeneration, and Parkinson's disease.

Hu WT, Chen-Plotkin A, Arnold SE, Grossman M, Clark CM, Shaw LM, McCluskey L, Elman L, Karlawish J, Hurtig HI, Siderowf A, Lee VM, Soares H, Trojanowski JQ.

Acta Neuropathol. 2010 Sep;120(3):385-99. doi: 10.1007/s00401-010-0723-9. Epub 2010 Jul 22. Review.

4.

Simultaneous analysis of cerebrospinal fluid biomarkers using microsphere-based xMAP multiplex technology for early detection of Alzheimer's disease.

Kang JH, Vanderstichele H, Trojanowski JQ, Shaw LM.

Methods. 2012 Apr;56(4):484-93. doi: 10.1016/j.ymeth.2012.03.023. Epub 2012 Apr 6. Review.

PMID:
22503777
5.

Fluid biomarkers in Alzheimer's disease - current concepts.

Rosén C, Hansson O, Blennow K, Zetterberg H.

Mol Neurodegener. 2013 Jun 21;8:20. doi: 10.1186/1750-1326-8-20. Review.

6.

Core candidate neurochemical and imaging biomarkers of Alzheimer's disease.

Hampel H, Bürger K, Teipel SJ, Bokde AL, Zetterberg H, Blennow K.

Alzheimers Dement. 2008 Jan;4(1):38-48. doi: 10.1016/j.jalz.2007.08.006. Epub 2007 Dec 21. Review.

PMID:
18631949
7.

[Biomarkers in Alzheimer's disease].

García-Ribas G, López-Sendón Moreno JL, García-Caldentey J.

Rev Neurol. 2014 Apr 1;58(7):308-17. Review. Spanish.

8.

Update on the core and developing cerebrospinal fluid biomarkers for Alzheimer disease.

Babić M, Svob Štrac D, Mück-Šeler D, Pivac N, Stanić G, Hof PR, Simić G.

Croat Med J. 2014 Aug 28;55(4):347-65. Review.

9.

Cerebrospinal fluid and plasma biomarkers in Alzheimer disease.

Blennow K, Hampel H, Weiner M, Zetterberg H.

Nat Rev Neurol. 2010 Mar;6(3):131-44. doi: 10.1038/nrneurol.2010.4. Epub 2010 Feb 16. Review.

PMID:
20157306
10.

Biomarkers in translational research of Alzheimer's disease.

Tarawneh R, Holtzman DM.

Neuropharmacology. 2010 Sep-Oct;59(4-5):310-22. doi: 10.1016/j.neuropharm.2010.04.006. Epub 2010 Apr 13. Review.

11.

Potential fluid biomarkers for pathological brain changes in Alzheimer's disease: Implication for the screening of cognitive frailty.

Ruan Q, D'Onofrio G, Sancarlo D, Greco A, Yu Z.

Mol Med Rep. 2016 Oct;14(4):3184-98. doi: 10.3892/mmr.2016.5618. Epub 2016 Aug 9. Review.

12.

Identifying and validating biomarkers for Alzheimer's disease.

Humpel C.

Trends Biotechnol. 2011 Jan;29(1):26-32. doi: 10.1016/j.tibtech.2010.09.007. Epub 2010 Oct 23. Review.

13.

Fluid biomarkers in Alzheimer disease.

Blennow K, Zetterberg H, Fagan AM.

Cold Spring Harb Perspect Med. 2012 Sep 1;2(9):a006221. doi: 10.1101/cshperspect.a006221. Review.

14.

Cerebrospinal fluid biomarkers of Alzheimer's disease in healthy elderly.

Randall C, Mosconi L, de Leon M, Glodzik L.

Front Biosci (Landmark Ed). 2013 Jun 1;18:1150-73. Review.

15.

A Review of Fluid Biomarkers for Alzheimer's Disease: Moving from CSF to Blood.

Blennow K.

Neurol Ther. 2017 Jul;6(Suppl 1):15-24. doi: 10.1007/s40120-017-0073-9. Epub 2017 Jul 21. Review.

16.

Cerebrospinal fluid biomarkers of Alzheimer's disease.

Fagan AM, Holtzman DM.

Biomark Med. 2010 Feb;4(1):51-63. doi: 10.2217/BMM.09.83. Review.

17.

Peptides and proteins in plasma and cerebrospinal fluid as biomarkers for the prediction, diagnosis, and monitoring of therapeutic efficacy of Alzheimer's disease.

Aluise CD, Sowell RA, Butterfield DA.

Biochim Biophys Acta. 2008 Oct;1782(10):549-58. doi: 10.1016/j.bbadis.2008.07.008. Epub 2008 Aug 7. Review.

18.

Cerebrospinal fluid protein biomarkers for Alzheimer's disease.

Blennow K.

NeuroRx. 2004 Apr;1(2):213-25. Review.

19.

Biomarkers in Alzheimer's disease analysis by mass spectrometry-based proteomics.

Liu Y, Qing H, Deng Y.

Int J Mol Sci. 2014 May 6;15(5):7865-82. doi: 10.3390/ijms15057865. Review.

20.

Cerebrospinal fluid biomarkers of neurovascular dysfunction in mild dementia and Alzheimer's disease.

Sweeney MD, Sagare AP, Zlokovic BV.

J Cereb Blood Flow Metab. 2015 Jul;35(7):1055-68. doi: 10.1038/jcbfm.2015.76. Epub 2015 Apr 22. Review.

Supplemental Content

Support Center